{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:58Z","timestamp":1786982518716,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02241-8","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T07:11:10Z","timestamp":1743750670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bioinformatics exploration of the S1PR1 receptor in various human cancers and its clinical relevance"],"prefix":"10.1007","volume":"16","author":[{"given":"Xing","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"6","key":"2241_CR1","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/ijms25063406","volume":"25","author":"EM Trifylli","year":"2024","unstructured":"Trifylli EM, Kriebardis AG, Koustas E, Papadopoulos N, Fortis SP, Tzounakas VL, Anastasiadi AT, Sarantis P, Vasileiadi S, Tsagarakis A, Aloizos G, Manolakopoulos S, Deutsch M. A current synopsis of the emerging role of extracellular vesicles and micro-RNAs in pancreatic cancer: a forward-looking plan for diagnosis and treatment. IJMS. 2024;25(6):3406.","journal-title":"IJMS"},{"key":"2241_CR2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249","DOI":"10.3322\/caac.21660"},{"issue":"6","key":"2241_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/boc.202000135","volume":"113","author":"F Colin","year":"2021","unstructured":"Colin F, Schauer K, Hamiche A, Martineau P, Borg J, Bednar J, Bertolin G, Camoin L, Collette Y, Dimitrov S, Fournier I, Hyenne V, Mendoza-Parra MA, Morelli X, Rond\u00e9 P, Sumara I, Tramier M, Schultz P, Goetz JG. The NANOTUMOR consortium \u2013 Towards the Tumor Cell Atlas. Biol Cell. 2021;113(6):272\u201380. https:\/\/doi.org\/10.1111\/boc.202000135.","journal-title":"Biol Cell"},{"key":"2241_CR4","doi-asserted-by":"crossref","unstructured":"Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko A, Kalluri R, Kshitiz. Systems Biology of Cancer Metastasis. Cell Syst 2019;9(2):109\u201327.","DOI":"10.1016\/j.cels.2019.07.003"},{"issue":"4","key":"2241_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40291-019-00401-5","volume":"23","author":"N Rostami","year":"2019","unstructured":"Rostami N, Nikkhoo A, Ajjoolabady A, Azizi G, Hojjat-Farsangi M, Ghalamfarsa G, Yousefi B, Yousefi M, Jadidi-Niaragh F. S1PR1 as a novel promising therapeutic target in cancer therapy. Mol Diagn Ther. 2019;23(4):467\u201387.","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"2241_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cvr\/cvaa046","volume":"117","author":"Y Kuang","year":"2021","unstructured":"Kuang Y, Li X, Liu X, Wei L, Chen X, Liu J, Zhuang T, Pi J, Wang Y, Zhu C, Gong X, Hu H, Yu Z, Li J, Yu P, Fan H, Zhang Y, Liu Z, Zhang L. Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction. Cardiovasc Res. 2021;117(2):585\u201399.","journal-title":"Cardiovasc Res"},{"key":"2241_CR7","doi-asserted-by":"crossref","first-page":"101469","DOI":"10.1016\/j.ijcha.2024.101469","volume":"53","author":"OM Bhat","year":"2024","unstructured":"Bhat OM, Mir RA, Nehvi IB, Wani NA, Dar AH, Zargar MA. Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases. IJC Heart Vascul. 2024;53:101469.","journal-title":"IJC Heart Vascul"},{"issue":"3","key":"2241_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/08923973.2018.1434792","volume":"40","author":"D Wang","year":"2018","unstructured":"Wang D. The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity. Immunopharmacol Immunotoxicol. 2018;40(3):187\u201392.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"2241_CR9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/biom13050818","volume":"13","author":"N Wang","year":"2023","unstructured":"Wang N, Li JY, Zeng B, Chen GL. Sphingosine-1-phosphate signaling in cardiovascular diseases. Biomolecules. 2023;13(5):818.","journal-title":"Biomolecules"},{"issue":"11","key":"2241_CR10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41423-022-00921-x","volume":"19","author":"L Tian","year":"2022","unstructured":"Tian L, Wu Y, Choi HJ, Sui X, Li X, Sofi MH, Kassir MF, Chen X, Mehrotra S, Ogretmen B, Yu XZ. S1P\/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission. Cell Mol Immunol. 2022;19(11):1235\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"2241_CR11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/cells9061515","volume":"9","author":"A Lucaciu","year":"2020","unstructured":"Lucaciu A, Brunkhorst R, Pfeilschifter J, Pfeilschifter W, Subburayalu J. Chapter Nine - S1PR1 signaling in cancer: a current perspective. Cells. 2020;9(6):1515.","journal-title":"Cells"},{"key":"2241_CR12","doi-asserted-by":"crossref","first-page":"102255","DOI":"10.1016\/j.tranon.2024.102255","volume":"52","author":"C Ding","year":"2025","unstructured":"Ding C, Wang J, Wang J, Niu J, Xiahou Z, Sun Z, Zhao Z, Zeng D. Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy. Transl Oncol. 2025;52:102255.","journal-title":"Transl Oncol"},{"key":"2241_CR13","doi-asserted-by":"crossref","first-page":"123037","DOI":"10.1016\/j.biomaterials.2024.123037","volume":"317","author":"Y Wang","year":"2025","unstructured":"Wang Y, Fan Y, Zhang X, Liu J, Sun D, Li L, Bai G, Liu X, Kang J, Zhang Y, Wang H. In situ production and precise release of bioactive GM-CSF and siRNA by engineered bacteria for macrophage reprogramming in cancer immunotherapy. Biomaterials. 2025;317:123037.","journal-title":"Biomaterials"},{"issue":"1","key":"2241_CR14","doi-asserted-by":"crossref","first-page":"011502","DOI":"10.1063\/5.0186042","volume":"8","author":"AJ Clevenger","year":"2024","unstructured":"Clevenger AJ, McFarlin MK, Gorley JPM, Solberg SC, Madyastha AK, Raghavan SA. Advances in cancer mechanobiology: metastasis, mechanics, and materials. APL Bioeng. 2024;8(1):011502.","journal-title":"APL Bioeng"},{"issue":"19","key":"2241_CR15","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.7150\/jca.98426","volume":"15","author":"R Mir","year":"2024","unstructured":"Mir R, Baba SK, Elfaki I, Algehainy N, Alanazi MA, Altemani FH, Tayeb FJ, Barnawi J, Husain E, Bedaiwi RI, Albalawi IA, Alhujaily M, Mir MM, Almotairi R, Alatwi HE, Albalawi AD. Unlocking the secrets of extracellular vesicles: orchestrating tumor microenvironment dynamics in metastasis, drug resistance, and immune evasion. J Cancer. 2024;15(19):6383\u2013415.","journal-title":"J Cancer"},{"issue":"10","key":"2241_CR16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1158\/2326-6066.CIR-19-0923","volume":"8","author":"G Hu","year":"2020","unstructured":"Hu G, Cheng P, Pan J, Wang S, Ding Q, Jiang Z, Cheng L, Shao X, Huang L, Huang J. An IL6\u2013adenosine positive feedback loop between CD73+ \u03b3\u03b4Tregs and CAFs promotes tumor progression in human breast cancer. Cancer Immunol Res. 2020;8(10):1273\u201386.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"2241_CR17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41419-024-06730-6","volume":"15","author":"D Del Rio","year":"2024","unstructured":"Del Rio D, Masi I, Caprara V, Ottavi F, Albertini Petroni G, Salvati E, Trisciuoglio D, Giannitelli SM, Bagnato A, Mauri E, Spadaro F, Rosan\u00f2 L. The \u03b2-arrestin1\/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential. Cell Death Dis. 2024;15(5):358.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2241_CR18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/biomedicines11030955","volume":"11","author":"S Huang","year":"2023","unstructured":"Huang S, Tan YQ, Zhou G. Aberrant activation of the STING-TBK1 pathway in \u03b3\u03b4 T cells regulates immune responses in oral lichen planus. Biomedicines. 2023;11(3):955.","journal-title":"Biomedicines"},{"issue":"8","key":"2241_CR19","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/s42255-024-01070-3","volume":"6","author":"T Zhou","year":"2024","unstructured":"Zhou T, Cheng J, He S, Zhang C, Gao MX, Zhang LJ, Sun JP, Zhu Y, Ai D. The sphingosine-1-phosphate receptor 1 mediates the atheroprotective effect of eicosapentaenoic acid. Nat Metab. 2024;6(8):1566\u201383.","journal-title":"Nat Metab"},{"key":"2241_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.12.003","author":"A Allman","year":"2024","unstructured":"Allman A, Gaudette BT, Kelly S, Alouche N, Carrington LJ, Perkey E, Brandstadter JD, Outen R, Vanderbeck A, Lederer K, Zhou Y, Faryabi RB, Robertson TF, Burkhardt JK, Tikhonova A, Aifantis I, Scarpellino L, Koch U, Radtke F, L\u00fctge M, De Martin A, Ludewig B, Tveriakhina L, Gossler A, Mosteiro L, Siebel CW, G\u00f3mez Atria D, Luther SA, Allman D, Maillard I. Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs. Immunity. 2024. https:\/\/doi.org\/10.1016\/j.immuni.2024.12.003.","journal-title":"Immunity"},{"issue":"13","key":"2241_CR21","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/cancers13133357","volume":"13","author":"H Zheng","year":"2021","unstructured":"Zheng H, Siddharth S, Parida S, Wu X, Sharma D. Tumor microenvironment: key players in triple negative breast cancer immunomodulation. Cancers (Basel). 2021;13(13):3357.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2241_CR22","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1111\/cas.13802","volume":"109","author":"M Nagahashi","year":"2018","unstructured":"Nagahashi M, Abe M, Sakimura K, Takabe K, Wakai T. The role of sphingosine-1-phosphate in inflammation and cancer progression. Cancer Sci. 2018;109(12):3671\u20138.","journal-title":"Cancer Sci"},{"issue":"7","key":"2241_CR23","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/0008-5472.CAN-17-1423","volume":"78","author":"M Nagahashi","year":"2018","unstructured":"Nagahashi M, Yamada A, Katsuta E, Aoyagi T, Huang WC, Terracina KP, Hait NC, Allegood JC, Tsuchida J, Yuza K, Nakajima M, Abe M, Sakimura K, Milstien S, Wakai T, Spiegel S, Takabe K. Targeting the SphK1\/S1P\/S1PR1 axis that links obesity, chronic inflammation, and breast cancer metastasis. Can Res. 2018;78(7):1713\u201325.","journal-title":"Can Res"},{"issue":"4","key":"2241_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/hsz-2023-0324","volume":"405","author":"L Jia","year":"2024","unstructured":"Jia L, Zhu S, Zhu M, Nie R, Huang L, Xu S, Luo Y, Su H, Huang S, Tan Q. Celastrol inhibits angiogenesis and the biological processes of MDA-MB-231 cells via the DEGS1\/S1P signaling pathway. Biol Chem. 2024;405(4):267\u201381.","journal-title":"Biol Chem"},{"issue":"5","key":"2241_CR25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/ph17050582","volume":"17","author":"M Han","year":"2024","unstructured":"Han M, Liu X, Hailati S, Nurahmat N, Dilimulati D, Baishan A, Aikebaier A, Zhou W. Evaluation of the efficacy of OSU-2S in the treatment of non-small-cell lung cancer and screening of potential targets of action. Pharmaceuticals. 2024;17(5):582.","journal-title":"Pharmaceuticals"},{"issue":"10","key":"2241_CR26","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1172\/JCI136928","volume":"130","author":"C Olesch","year":"2020","unstructured":"Olesch C, Sirait-Fischer E, Berkefeld M, Fink AF, Susen RM, Ritter B, Michels BE, Steinhilber D, Greten FR, Savai R, Takeda K, Br\u00fcne B, Weigert A. S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion. J Clin Investig. 2020;130(10):5461\u201376.","journal-title":"J Clin Investig"},{"issue":"2","key":"2241_CR27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/1871520621666210401105344","volume":"22","author":"J Long","year":"2021","unstructured":"Long J, Yao Z. SphK1 promotes cancer progression through activating JAK\/STAT pathway and up-regulating s1pr1 expression in colon cancer cells. Anticancer Agents Med Chem. 2021;22(2):254\u201360.","journal-title":"Anticancer Agents Med Chem"},{"key":"2241_CR28","volume":"12","author":"M Ye","year":"2021","unstructured":"Ye M, Gai Y, Ji H, Jiang Y, Qiao P, Wang W, Zhang Y, Xia X, Lan X. A novel radioimmune 99mtc-labeled tracer for imaging sphingosine 1-phosphate receptor 1 in tumor xenografts: an in vitro and in vivo study. Front Immunol. 2021;12: 660842.","journal-title":"Front Immunol"},{"issue":"7","key":"2241_CR29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41419-024-06920-2","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Shen S, You J, Wang Z, Li Y, Chen Y, Tuo Y, Chen D, Yu H, Zhang J, Wang F, Pang X, Xiao Z, Lan Q, Wang Y. PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration. Cell Death Dis. 2024;15(7):524.","journal-title":"Cell Death Dis"},{"key":"2241_CR30","doi-asserted-by":"publisher","first-page":"668884","DOI":"10.3389\/fimmu.2021.668884\/full","volume":"12","author":"T Burkard","year":"2021","unstructured":"Burkard T, Dreis C, Herrero San Juan M, Huhn M, Weigert A, Pfeilschifter JM, Radeke HH. Enhanced CXCR4 expression of human CD8Low T lymphocytes is driven by S1P4. Front Immunol. 2021;12:668884. https:\/\/doi.org\/10.3389\/fimmu.2021.668884\/full.","journal-title":"Front Immunol"},{"key":"2241_CR31","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20194337","author":"J Lv","year":"2020","unstructured":"Lv J, Zhu Y, Ji A, Zhang Q, Liao G. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer. 2020. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20194337."},{"issue":"2","key":"2241_CR32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1535-7163.MCT-17-1141","volume":"18","author":"D Garandeau","year":"2019","unstructured":"Garandeau D, Noujar\u00e8de J, Leclerc J, Imbert C, Garcia V, Bats ML, Rambow F, Gilhodes J, Filleron T, Meyer N, Brayer S, Arcucci S, Tartare-Deckert S, S\u00e9gui B, Marine JC, Levade T, Bertolotto C, Andrieu-Abadie N. Targeting the sphingosine 1-phosphate axis exerts potent antitumor activity in BRAFi-resistant melanomas. Mol Cancer Therap. 2019;18(2):289\u2013300.","journal-title":"Mol Cancer Therap"},{"key":"2241_CR33","doi-asserted-by":"publisher","first-page":"1048758","DOI":"10.3389\/fimmu.2022.1048758\/full","volume":"13","author":"KR Plunkett","year":"2022","unstructured":"Plunkett KR, Armitage JD, Inderjeeth AJ, McDonnell AM, Waithman J, Lau PKH. Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management. Front Immunol. 2022;13:1048758. https:\/\/doi.org\/10.3389\/fimmu.2022.1048758\/full.","journal-title":"Front Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02241-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T07:11:58Z","timestamp":1743750718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02241-8","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20194337","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for this study as it involves the use of publicly available data and bioinformatics analysis without direct human participation or clinical samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as this manuscript does not contain data from any individual person.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"449"}}